Xianqiang Liu

Construction and evaluation of a novel humanized HER2-specific chimeric receptor

Meili Sun, Huan Shi, Chuanyong Liu et al. · Breast Cancer Research · 2014 · 125 citations · Full text

Life Sciences, Immunology, Oncology +17

Driving better and safer HER2-specific CARs for cancer therapy

Xianqiang Liu, Nan Zhang, Huan Shi · Oncotarget · 2017 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer

Chunli Yin, Xiaoyan Lin, Yige Wang et al. · Cellular Oncology · 2020 · 58 citations · Full text

Medicine, Molecular Biology, Oncology +16

Fabrication and characterization of solid lipid nano-formulation of astraxanthin against DMBA-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/Maf-1/PTEN pathway

Tao Sun, Jun Gao, Dan Han et al. · Drug Delivery · 2019 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of Novel Variants of Metadherin in Breast Cancer

Xianqiang Liu, Ning Zhang, Xiao Li et al. · PLoS ONE · 2011 · 34 citations · Full text

Life Sciences, Genetics, Oncology +11